====== BML-284 0.09μM R08 exp460 ====== ==== Mechanism of Action ==== Wnt agonist, GSK3-‘_ dependent, activates ‘_-catenin/TCF-dependent transcription * **Class / Subclass 1:** Signal Transduction / GPCR Agonist * **Class / Subclass 2:** Gene Regulation / Transcription Activator ==== Technical Notes ==== * **PubChem Name:** %%Wnt Agonist%% * **Synonyms:** N/A * **CAS #:** 853220-52-7 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/11210285|11210285]] * **IUPAC:** %%4-N-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine%% * **INCHI Name:** InChI=1S/C19H18N4O3/c1-24-14-4-2-3-13(8-14)15-9-18(23-19(20)22-15)21-10-12-5-6-16-17(7-12)26-11-25-16/h2-9H,10-11H2,1H3,(H3,20,21,22,23) * **INCHI Key:** FABQUVYDAXWUQP-UHFFFAOYSA-N * **Molecular Weight:** 350.4 * **Canonical SMILES:** COC1=CC=CC(=C1)C2=CC(=NC(=N2)N)NCC3=CC4=C(C=C3)OCO4 * **Isomeric SMILES:** N/A * **Molecular Formula:** C19H18N4O3 {{:chemogenomics:structures:chem-0270.svg?nolink}} * **Supplier Name:** Med Chem Express * **Catalog #:** HY-19987 * **Lot #:** 20280 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C19H18N4O3 351.14517; found 351.14569 * **Platform ID:** BML284 * **Min:** 2.1177; **Max:** 99.1512 {{:chemogenomics:dose_response:dr_506.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |0.0660 | | IC20 |0.0870 | | IC30 |0.1046 | | IC40 |0.1216 | | IC50 |0.1396 | | IC60 |0.1603 | | IC70 |0.1863 | | IC80 |0.2239 | | IC90 |0.2952 | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 90nM * **Days of incubation**: 8 * **Doublings**: 4.1 * **Numbers of reads**: 14681997 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |63/37|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/BML-284_0.09uM_Round-8_exp460.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp460.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:K:KIF18A|KIF18A]]|-4.14|0.00| |[[:human_genes:A:ASPM|ASPM]]|-4.11|0.00| |[[:human_genes:B:BRD1|BRD1]]|-3.96|0.00| |[[:human_genes:M:MAPRE1|MAPRE1]]|-3.83|0.00| |[[:human_genes:S:SEPHS1|SEPHS1]]|-3.69|0.00| |[[:human_genes:Q:QRICH1|QRICH1]]|-3.54|0.00| |[[:human_genes:A:ARID4B|ARID4B]]|-3.52|0.00| |[[:human_genes:M:MSI2|MSI2]]|-3.49|0.00| |[[:human_genes:T:TCF4|TCF4]]|-3.42|0.00| |[[:human_genes:P:PDS5B|PDS5B]]|-3.38|0.00| |[[:human_genes:Y:YPEL5|YPEL5]]|-3.38|0.00| |[[:human_genes:D:DLGAP5|DLGAP5]]|-3.37|0.00| |[[:human_genes:K:KIF15|KIF15]]|-3.31|0.00| |[[:human_genes:K:KIFC1|KIFC1]]|-3.30|0.00| |[[:human_genes:T:TRIP13|TRIP13]]|-3.27|0.00| |[[:human_genes:C:CNOT2|CNOT2]]|-3.23|0.00| |[[:human_genes:E:ESCO2|ESCO2]]|-3.22|0.00| |[[:human_genes:U:UBE4B|UBE4B]]|-3.11|0.00| |[[:human_genes:P:PSME3|PSME3]]|-3.06|<0.01| |[[:human_genes:K:KNTC1|KNTC1]]|-2.92|<0.01| |[[:human_genes:T:TACC3|TACC3]]|-2.91|<0.01| |[[:human_genes:V:VPS25|VPS25]]|-2.88|0.10| |[[:human_genes:H:HSPA4|HSPA4]]|-2.87|<0.01| |[[:human_genes:E:EDF1|EDF1]]|-2.87|<0.01| |[[:human_genes:K:KATNB1|KATNB1]]|-2.77|<0.01| |[[:human_genes:Z:ZWILCH|ZWILCH]]|-2.77|<0.01| |[[:human_genes:F:FDPS|FDPS]]|-2.73|<0.01| |[[:human_genes:R:RC3H1|RC3H1]]|-2.68|<0.01| |[[:human_genes:S:SZT2|SZT2]]|-2.65|<0.01| |[[:human_genes:V:VBP1|VBP1]]|-2.65|<0.01| |[[:human_genes:P:PIGO|PIGO]]|2.47|0.06| |[[:human_genes:M:MTA1|MTA1]]|2.47|0.03| |[[:human_genes:V:VAPA|VAPA]]|2.51|0.01| |[[:human_genes:Z:ZC3H7A|ZC3H7A]]|2.53|0.01| |[[:human_genes:A:ASXL2|ASXL2]]|2.57|0.02| |[[:human_genes:S:SRM|SRM]]|2.60|0.01| |[[:human_genes:F:FKBP5|FKBP5]]|2.61|<0.01| |[[:human_genes:O:OTUD5|OTUD5]]|2.66|0.03| |[[:human_genes:S:SPOP|SPOP]]|2.67|<0.01| |[[:human_genes:S:SRF|SRF]]|2.70|0.01| |[[:human_genes:C:CBX3|CBX3]]|2.73|<0.01| |[[:human_genes:M:MBTPS1|MBTPS1]]|2.79|0.02| |[[:human_genes:S:SP3|SP3]]|2.96|<0.01| |[[:human_genes:N:NUMA1|NUMA1]]|3.05|<0.01| |[[:human_genes:F:FBXO11|FBXO11]]|3.08|0.00| |[[:human_genes:I:ID3|ID3]]|3.10|0.00| |[[:human_genes:L:LCMT1|LCMT1]]|3.12|0.00| |[[:human_genes:P:PPP6R3|PPP6R3]]|3.12|0.00| |[[:human_genes:T:TP53BP1|TP53BP1]]|3.14|<0.01| |[[:human_genes:N:NDE1|NDE1]]|3.14|0.00| |[[:human_genes:A:ACTB|ACTB]]|3.20|0.00| |[[:human_genes:K:KIF18B|KIF18B]]|3.29|0.00| |[[:human_genes:U:USP28|USP28]]|3.31|0.00| |[[:human_genes:A:ATAT1|ATAT1]]|3.50|0.00| |[[:human_genes:K:KHDRBS1|KHDRBS1]]|3.58|0.00| |[[:human_genes:Z:ZNF592|ZNF592]]|3.75|0.00| |[[:human_genes:C:CCNF|CCNF]]|4.04|0.00| |[[:human_genes:T:TMEM161B|TMEM161B]]|4.54|0.00| |[[:human_genes:T:TP53|TP53]]|5.73|0.00| |[[:human_genes:A:ATP1A1|ATP1A1]]|6.06|0.00| ^Screen^Correlation^Plot^ |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.207|| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.172|| |[[:results:exp59|UMK57 1μM R01 exp59]]|0.172|| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.136|| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.121|| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.121|| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.116|| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|0.109|| |[[:results:exp67|BVD-523 15μM R02 exp67]]|0.107|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.106|| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.104|| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.094|| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|0.076|| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|0.075|| |[[:results:exp502|Milciclib 2μM R08 exp502]]|0.067|| |[[:results:exp360|Genistein 15μM R07 exp360]]|0.063|| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|0.062|| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.062|| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.061|| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|0.058|| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|0.057|| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.056|| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.055|| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|0.055|| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.055|| |[[:results:exp346|CoCl2 18μM R07 exp346]]|0.054|| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|0.053|| |[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.053|| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.053|| |[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.051|| |[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.137|| |[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.095|| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.089|| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|0.071|| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.064|| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.051|| {{:chemogenomics:comparison_plots:exp217_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp106_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp59.png?nolink |}} {{:chemogenomics:comparison_plots:exp215_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp228_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp179_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp190_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp103_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp67.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp517.png?nolink |}} {{:chemogenomics:comparison_plots:exp184_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp60.png?nolink |}} {{:chemogenomics:comparison_plots:exp231_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp243_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp502.png?nolink |}} {{:chemogenomics:comparison_plots:exp360_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp107_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp329_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp526.png?nolink |}} {{:chemogenomics:comparison_plots:exp46_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp290_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp485.png?nolink |}} {{:chemogenomics:comparison_plots:exp357_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp525.png?nolink |}} {{:chemogenomics:comparison_plots:exp435_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp346_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp45_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp354_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp500.png?nolink |}} {{:chemogenomics:comparison_plots:exp356_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp312_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp311_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp310_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp460_vs_exp97.png?nolink |}} {{:chemogenomics:comparison_plots:exp175_vs_exp460.png?nolink |}} {{:chemogenomics:comparison_plots:exp2_vs_exp460.png?nolink |}} ^GO Term^Fold Change^Genes^ |kinetochore microtubule|95.22|KIF18A,KNTC1,ZWILCH| |chromosome localization|30.07|KIF18A,MAPRE1,DLGAP5,KIFC1,KATNB1| |regulation of sister chromatid segregation|27.74|DLGAP5,TRIP13,KNTC1,TACC3,ZWILCH| |mitotic sister chromatid segregation|25.02|KIF18A,MAPRE1,DLGAP5,KIFC1,KNTC1,KATNB1| |sister chromatid segregation|24.31|KIF18A,MAPRE1,DLGAP5,KIFC1,KNTC1,KATNB1| |spindle pole|23.53|ASPM,MAPRE1,YPEL5,DLGAP5,KNTC1,TACC3,KATNB1| |mitotic spindle|22.47|KIF18A,ASPM,MAPRE1,YPEL5,DLGAP5,KIFC1,TACC3| |mitotic nuclear division|20.90|KIF18A,MAPRE1,DLGAP5,KIFC1,KNTC1,KATNB1| |nuclear chromosome segregation|20.78|KIF18A,ASPM,MAPRE1,DLGAP5,KIFC1,TRIP13,KNTC1,KATNB1| |chromosome segregation|15.68|KIF18A,ASPM,MAPRE1,DLGAP5,KIFC1,TRIP13,ESCO2,KNTC1,KATNB1| |spindle|15.14|KIF18A,ASPM,MAPRE1,YPEL5,DLGAP5,KIF15,KIFC1,KNTC1,TACC3,KATNB1,ZWILCH| |nuclear division|15.04|KIF18A,ASPM,MAPRE1,DLGAP5,KIFC1,TRIP13,KNTC1,KATNB1| |organelle fission|13.89|KIF18A,ASPM,MAPRE1,DLGAP5,KIFC1,TRIP13,KNTC1,KATNB1| |chromosome organization|11.69|KIF18A,MAPRE1,PDS5B,DLGAP5,KIFC1,TRIP13,ESCO2,KNTC1,KATNB1| |microtubule|10.53|KIF18A,ASPM,MAPRE1,KIF15,KIFC1,KNTC1,KATNB1,ZWILCH| |mitotic cell cycle process|9.97|KIF18A,MAPRE1,DLGAP5,KIFC1,TRIP13,KNTC1,TACC3,KATNB1,ZWILCH| |mitotic cell cycle|9.52|KIF18A,MAPRE1,DLGAP5,KIF15,KIFC1,TRIP13,KNTC1,TACC3,KATNB1,ZWILCH| |cell division|9.03|ASPM,MAPRE1,PDS5B,KIFC1,KNTC1,TACC3,KATNB1,ZWILCH| |cell cycle process|7.86|KIF18A,ASPM,MAPRE1,PDS5B,DLGAP5,KIFC1,TRIP13,ESCO2,KNTC1,TACC3,KATNB1,ZWILCH| ^GO Term^Fold Change^Genes^ |mitotic cell cycle process|8.56|TP53,CCNF,KHDRBS1,KIF18B,NDE1,LCMT1,NUMA1,MBTPS1| |mitotic cell cycle|7.36|TP53,CCNF,KHDRBS1,KIF18B,NDE1,LCMT1,NUMA1,MBTPS1|